Literature DB >> 26829520

Characterization of the Anticoagulative Constituents of Angelicae Sinensis Radix and Their Metabolites in Rats by HPLC-DAD-ESI-IT-TOF-MSn.

Lu Wang1, Shuai Huang1, Bing Chen2, Xin-Yu Zang1, Dan Su1, Jing Liang1, Feng Xu1, Guang-Xue Liu1, Ming-Ying Shang1, Shao-Qing Cai1.   

Abstract

Angelicae Sinensis Radix is commonly used in traditional Chinese medicine. Pharmacological studies show that Angelicae Sinensis Radix has clear anticoagulant activity. Therefore, in this study, the anticoagulant activity of crude Angelicae Sinensis Radix extracts was investigated by measuring the thrombin times of the extracts. The results revealed that the petroleum ether-soluble fraction of Angelicae Sinensis Radix exhibited significant anticoagulant activity in vitro, and 26 compounds were characterized by high-performance liquid chromatography with diode array detection combined with electrospray ionization ion trap time-of-flight multistage mass spectrometry. In addition, 5 prototype constituents, 24 in vivo metabolites in rat urine and 7 prototype constituents, and 9 in vitro metabolites in the rat hepatic S9 incubation system of the petroleum ether-soluble fraction were tentatively identified. All metabolites were found from Angelicae Sinensis Radix for the first time. Among them, 13 (three ferulic acid-related constituents, six senkyunolide D-related constituents, and four senkyunolide F-related constituents) were identified as new metabolites (new compounds). This study is the first to qualitatively characterize the chemical constituents of the potent anticoagulative extract of Angelicae Sinensis Radix and to explore its metabolism. The result is a notable improvement in the discovery of Angelicae Sinensis Radix metabolites, and it provides the chemical basis for the effective forms and pharmacodynamic substances (prototypes, metabolites, or both) of the anticoagulant activity of Angelicae Sinensis Radix. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26829520     DOI: 10.1055/s-0035-1558309

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  4 in total

Review 1.  Better Bioactivity, Cerebral Metabolism and Pharmacokinetics of Natural Medicine and Its Advanced Version.

Authors:  Jiaxi Xie; Cailing Zhong; Tingting Wang; Dan He; Luyang Lu; Jie Yang; Ziyi Yuan; Jingqing Zhang
Journal:  Front Pharmacol       Date:  2022-06-27       Impact factor: 5.988

2.  Acupoint herbal plaster for patients with primary dysmenorrhea: study protocol for a randomized controlled trial.

Authors:  Siyi Yu; Yueqiang Wen; Wanting Xia; Mingxiao Yang; Zhengtao Lv; Xiaoji Li; Wenyao Li; Sha Yang; Youping Hu; Fanrong Liang; Jie Yang
Journal:  Trials       Date:  2018-07-03       Impact factor: 2.279

3.  Identification of Chemical Components of Qi-Fu-Yin and Its Prototype Components and Metabolites in Rat Plasma and Cerebrospinal Fluid via UPLC-Q-TOF-MS.

Authors:  Hengyu Li; Hongwei Zhao; Yong Yang; Dongmei Qi; Xiaorui Cheng; Jiafeng Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-28       Impact factor: 2.629

4.  Quality assessment and Q-markers discovery of Tongsaimai tablet by integrating serum pharmacochemistry and network pharmacology for anti-atherosclerosis benefit.

Authors:  Yanfen Cheng; Meng Xiao; Jiamei Chen; Di Wang; Yichen Hu; Chenfeng Zhang; Tuanjie Wang; Chaomei Fu; Yihan Wu; Jinming Zhang
Journal:  Chin Med       Date:  2022-09-02       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.